Join the FDA Office of Women’s Health (OWH) and Center for Drug Evaluation and Research (CDER) for a public hybrid workshop on Testosterone Use in Menopausal Women
The Food and Drug Administration's (FDA) Office of Women's Health and the Center for Drug Evaluation and Research are announcing a public workshop titled "Testosterone Use in Menopausal Women."
The purpose of the public workshop is to examine the current scientific evidence and critical knowledge gaps related to testosterone use in menopausal women to help inform future research and potential drug development of testosterone products for menopausal women.
The public workshop will be held on September 17, 2026, from 9:00 a.m. to 4:30 p.m. Eastern Time as a hybrid...
ExcelMale Newsletter Signup
Stay Informed with Our Newsletter
Get the latest men's health insights, expert advice, and community updates delivered to your inbox.